Max Planck, Alnylam Sue Whitehead, MIT, UMass for Breach of Contract in RNAi Patent Filings

According to court documents, the defendants have allegedly misappropriated and misrepresented as their own inventions solely owned by Max Planck and exclusively licensed by Alnylam.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.